Revumenib (CAS 2169919-21-3) is supplied by Monuo Chemical for specialty chemical and custom synthesis purchasing. It is also referenced as SNDX-5613 and SNDX5613 free base. Buyers typically search by product name or CAS when sourcing menin–MLL interaction inhibitors for oncology and cell-biology research.
Key Specifications at a Glance
| Product Name | Revumenib |
|---|---|
| CAS Number | 2169919-21-3 |
| Molecular Formula | C32H47FN6O4S |
| Molecular Weight | 630.8 g/mol |
| Chemical Class | Small-molecule menin–MLL inhibitor / specialty biochemical |
| Purity / Specification | 98.0%–102.0% on anhydrous basis; confirm assay on the batch COA |
| Typical Use Area | Oncology / biochemical R&D; menin–KMT2A (MLL) interaction studies |
| Category | Custom synthesis |
| Documents | COA, TDS, SDS on request |
| Supply Origin | China | Worldwide shipping |
What Is Revumenib?
Revumenib (CAS 2169919-21-3), also known as SNDX-5613, is a small-molecule inhibitor of the menin–MLL (KMT2A) protein–protein interaction. Molecular formula C32H47FN6O4S; molecular weight about 630.8 g/mol. Always match CAS 2169919-21-3 on the batch COA.
In laboratory literature it is described as a potent, selective menin–MLL binder (reported binding Ki about 0.149 nM; cell-based IC50 often cited in the low-nanomolar range) and is widely used as a research tool for MLL-rearranged (MLL-r) acute leukemia models, including AML and ALL related pathway studies. Monuo Chemical supplies Revumenib as a specialty chemical raw material under Custom synthesis, with batch identity documentation (COA / SDS). Finished-product claims, labeling and local regulatory filings remain the brand manufacturer’s responsibility. Confirm grade and assay against the batch COA for your intended method.
Synonyms & Search Names
- Revumenib
- SNDX-5613 / SNDX 5613 / SNDX5613
- SNDX5613 free base
- N-ethyl-2-[4-[7-[[4-(ethylsulfonylamino)cyclohexyl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]pyrimidin-5-yl]oxy-5-fluoro-N-propan-2-ylbenzamide
- CAS 2169919-21-3
Applications
In specialty biochemical and oncology R&D projects, Revumenib is commonly reviewed for:
- Menin–MLL (menin–KMT2A) protein–protein interaction inhibition studies
- MLL-rearranged (MLL-r) acute leukemia model systems, including AML- and ALL-related pathway research
- NPM1-mutant leukemia research contexts where menin pathway probes are evaluated
- Catalog purchasing for custom synthesis of specialty small-molecule inhibitor biochemicals
Compare related specialty items such as Novobiocin sodium (CAS 1476-53-5) in the same Custom synthesis range.
Handling & Use Notes
- Assay check: Confirm specification / assay for Revumenib on the batch COA before use (catalog listing: 98.0%–102.0% on anhydrous basis).
- Container handling: Keep sealed and dry; protect from unnecessary light and heat during sampling.
- Process fit: Verify solubility and stability in your intended solvent / media system (DMSO is commonly cited in research catalogs) before scale-up.
- Safety: Follow the SDS for storage, PPE and waste handling. Use the batch SDS as the controlling safety document.
Need assay or packing discussion? Email [email protected] or use the contact form.
Packaging, Storage & Logistics
| Standard Pack Sizes | 50 g / 100 g bottles; 500 g / 1 kg packs (custom packing available) |
|---|---|
| Storage | Keep sealed, dry and protected from light and heat. Follow the batch COA and SDS |
| Shelf Life | Confirm shelf life on the COA for each lot |
| MOQ | Commercial MOQ discussed per project (often from 50 g); larger packs available on request |
| Lead Time | Stock items often ship promptly; custom pack / large lots typically 7–14 working days |
Quality & Documentation
For Revumenib (CAS 2169919-21-3), Monuo Chemical can provide:
- Certificate of Analysis (COA)
- Technical Data Sheet (TDS) and Safety Data Sheet (SDS)
- CAS / product-name confirmation for your purchase file
- Flexible packing from grams to kilograms
- FOB / CIF / DAP terms as agreed
Our team aims to return technical data and quotations within 24 hours. See also Custom synthesis.
Request a Quote
Share your target assay, pack size and destination. We will confirm availability and documentation for Revumenib CAS 2169919-21-3.
Request a Quote | Email: [email protected]
Frequently Asked Questions
What is Revumenib (CAS 2169919-21-3)?
It is a small-molecule menin–MLL (KMT2A) interaction inhibitor, also known as SNDX-5613. Monuo Chemical lists it under Custom synthesis. Match CAS 2169919-21-3 on the batch COA.
Is SNDX-5613 the same material?
Yes. SNDX-5613 is the common research / development code for Revumenib (free base). Always put CAS 2169919-21-3 on RFQs and POs to avoid mix-ups with salt forms.
What is the molecular formula and weight?
Listed values are molecular formula C32H47FN6O4S; molecular weight about 630.8 g/mol. Confirm on the batch COA/TDS.
Where is Revumenib typically used in R&D?
Typical laboratory uses include menin–MLL pathway inhibition studies and MLL-rearranged acute leukemia model research. Monuo supplies raw-material identity documentation only; finished-product claims remain the customer’s responsibility.
What specification do you supply?
A catalog listing for this CAS is 98.0%–102.0% on anhydrous basis. Exact assay is confirmed on the Certificate of Analysis for each lot. Share your target grade when you request a quote.
How should Revumenib be stored?
Keep sealed, dry and protected from unnecessary light and heat. Follow the batch SDS and COA for controlling storage conditions.
How do I request a quotation for CAS 2169919-21-3?
Share target assay, pack size and destination via the Request a Quote page or email [email protected]. We aim to reply within 24 hours.
Which related Custom synthesis products can I review?
You may also review Novobiocin sodium (CAS 1476-53-5) and Rapamycin (CAS 53123-88-9), or open the full Custom synthesis catalog.
Related Products
- Novobiocin sodium (CAS 1476-53-5)
- Rapamycin (CAS 53123-88-9)
- Bis(4-methacryloylthiophenyl) Sulfide (CAS 129283-82-5)
- View all Custom synthesis
Disclaimer: Information is for specialty chemical raw-material identification and technical reference. Finished-product claims and regulatory filings remain the customer’s responsibility. Verify each lot against the supplied COA and SDS. Trade terms are FOB / CIF / DAP as agreed.
